KYNTRA BIO, INC. (KYNB)
Data as of , from SEC Form 4 filings.
See up to 3 months of KYNB. The 7-day demo opens the 1M and 3M ranges and puts KYNB on your watchlist.
Start 7-day demoLatest KYNB insider trades
About KYNTRA BIO, INC. (KYNB)
The SEC lists KYNTRA BIO, INC. under CIK 0000921299, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
KYNB Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 1 | 14,000 | |
| Tax withholding / forfeiture | 2 | 231 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
KYNB insider transactions (Form 4)
2723 Form 4 filings on record, the earliest from Dec 9, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Andrew E. Singer - Director | Grant or award | Stock Option (Right to Buy) | 14,000 | $0.00 | - | |
| Thane Wettig - Officer | Tax withholding / forfeiture | Common Stock | 209 footnote F1 | $8.55 | $2K | |
| ||||||
| David Delucia - Officer | Tax withholding / forfeiture | Common Stock | 22 footnote F1 | $8.55 | $188 | |
| ||||||
 Maykin Ho | Grant or award | Stock Option (Right to Buy) | 7,000 | $0.00 | - | |
| Jeffrey L. Edwards | Grant or award | Stock Option (Right to Buy) | 7,000 | $0.00 | - | |
| Michael Kauffman | Grant or award | Stock Option (Right to Buy) | 7,000 | $0.00 | - | |
| James A. Schoeneck | Grant or award | Stock Option (Right to Buy) | 7,000 | $0.00 | - | |
| Thane Wettig - Officer | Tax withholding / forfeiture | Common Stock | 198 footnote F1 | $6.71 | $1K | |
| ||||||
| David Delucia - Officer | Tax withholding / forfeiture | Common Stock | 52 footnote F1 | $6.71 | $349 | |
| ||||||
| Thane Wettig - Officer | Open-market purchase | Common Stock | 2,800 | $7.09 | $20K | |
| Thane Wettig - Officer | Open-market purchase | Common Stock | 2,800 | $7.09 | $20K | |
| Thane Wettig - Officer | Tax withholding / forfeiture | Common Stock | 277 footnote F1 | $6.84 | $2K | |
| ||||||
| David Delucia - Officer | Tax withholding / forfeiture | Common Stock | 60 footnote F1 | $6.84 | $410 | |
| ||||||
| Thane Wettig - Officer | Grant or award | Stock Option (Right to Buy) | 60,000 | $0.00 | - | |
| David Delucia - Officer | Grant or award | Stock Option (Right to Buy) | 26,000 | $0.00 | - | |
| Thane Wettig - Officer | Open-market purchase | Common Stock | 1,000 | $9.18 | $9K | |
| Thane Wettig - Officer | Open-market purchase | Common Stock | 2,700 | $9.10 | $25K | |
| David Delucia - Officer | Tax withholding / forfeiture | Common Stock | 51 | $7.83 | $399 | |
| David Delucia - Officer | Tax withholding / forfeiture | Common Stock | 53 | $12.10 | $641 | |
| Thane Wettig - Officer | Tax withholding / forfeiture | Common Stock | 246 | $7.83 | $2K | |
| Thane Wettig - Officer | Tax withholding / forfeiture | Common Stock | 248 | $12.10 | $3K | |
| James A. Schoeneck | Open-market purchase | Common Stock | 23,567 | $5.07 | $119K | |
| Jeffrey L. Edwards | Grant or award | Stock Option (Right to Buy) | 120,000 | $0.00 | - | |
| Juan Graham - Officer | Tax withholding / forfeiture | Common Stock | 1,446 | $0.34 | $495 | |
| Juan Graham - Officer | Tax withholding / forfeiture | Common Stock | 1,066 | $0.34 | $365 | |
| Thane Wettig - Officer | Tax withholding / forfeiture | Common Stock | 2,363 | $0.34 | $808 | |
| Christine Chung - Officer | Tax withholding / forfeiture | Common Stock | 2,792 | $0.34 | $955 | |
KYNB insider trading FAQ
What is the latest insider trade for KYNB?
KYNTRA BIO, INC. (KYNB) had 3 insider filings in the last 90 days, with the most recent on 2026-10-06. The full record for KYNB runs to 23 Form 4 filings, the earliest from 2024-12-09. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying KYNB stock?
No insider purchases of KYNB were filed in the last 90 days. 5 purchases are on record for this company.
How many insiders are selling KYNB stock?
No insider sales of KYNB were filed in the last 90 days.
Where can I see KYNB SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects KYNB Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Andrew E. Singer view on EDGAR
- - Thane Wettig view on EDGAR
- - David Delucia view on EDGAR
- - Maykin Ho view on EDGAR
- - Jeffrey L. Edwards view on EDGAR
- - Michael Kauffman view on EDGAR
- - James A. Schoeneck view on EDGAR
- - Thane Wettig view on EDGAR
- - David Delucia view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where KYNB's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow KYNB with a 7-day demo
- KYNB on your watchlist
- Every KYNB Form 4 filing on record
- Up to 3 months of KYNB price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
